Skip to content
2000
Volume 24, Issue 10
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Background: It has been suggested that genetic factors may be substantially linked to allergy disorders. Objective: This study aims to investigate the relationship between the serum specific Immunoglobulin E (sIgE), blood eosinophil, and the polymorphisms of glycoprotein Ib alpha gene () rs6065, platelet endothelial aggregation receptor 1 gene () rs12041331, and plasminogen activator inhibitor 1 gene () rs1799762. Methods: From the Peking Union Medical College Hospital, this study enrolled 60 healthy participants and 283 participants with allergic diseases. TaqMan-minor groove binder (MGB) quantitative polymerase chain reaction (qPCR) was used to examine the gene polymorphisms in each group. Results: The TaqMan-MGB qPCR results were completely consistent with the DNA sequencing results, according to other studies in this medical center (Kappa =1, <0.001). The rs6065, rs12041331, and rs1799762 polymorphisms did not show different distribution between allergy patients and healthy individuals. Concerning allergy patients, the CT (n=33) genotype of rs6065 had higher blood eosinophil level than the CC (n=250) genotype (0.59, IQR 0.32-0.72 vs 0.31, IQR 0.15-0.61, *109/L, =0.005). The serum sIgE of AA (n=46) genotype of rs12041331 was lower (median 3.7, interquartile quartiles (IQR) 0.2-16.8, kU/L) than the GA (n=136) and GG (n=101) genotypes (GA median 16.3, IQR 3.1-46.3, kU/L, = 0.002; GG median 12.9, IQR 3.0-46.9, kU/L, =0.003). The GA genotypes of PEAR1 rs12041331were with higher blood eosinophil levels (median 0.42, IQR 0.17-0.74 *109/L) than the AA genotype (median 0.25, IQR 0.15-0.41*109/L, =0.012). The sIgE of the 5G5G (n=44) genotype of rs1799762 was lower (median 5.0, IQR 0.1-22.8, kU/L) than the 4G5G (n=144) (median 17.3, IQR 3.7-46.0, kU/L, = 0.012). Conclusion: The rs6065, rs12041331, and rs1799762 polymorphisms may be associated with the genetic susceptibility of serum sIgE or blood eosinophil in Chinese allergic disease patients.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303285101240118062549
2024-08-01
2024-11-15
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/0118715303285101240118062549
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test